EGFR and lung carcinoma: In our cohort, we identified eight lung cancer patients with EGFR C797S mutation occurring in cis with EGFR T790M mutation (Fig. 2b–e and Supplementary Fig. 2); in one patient, serial sampling confirmed that the EGFR C797S mutation occurred after the AZD9291 therapy (Fig. 2e).